Dr. Ashley King, MD
What this data tells you about Dr. King
Dr. Ashley King is an urology physician in Pensacola, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. King performed 13,173 Medicare services across 3,564 unique beneficiaries.
Between the years covered by Open Payments, Dr. King received a total of $4,594 from 36 pharmaceutical and/or device companies across 211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. King is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Florida License Status
FL DOH · MQA| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 121361 | Clear | January 31, 2027 | — |
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 7,375 | $0 | $3 |
| Identification of organisms by genetic analysis, amplified probe technique | 1,428 | $34 | $156 |
| Automated urinalysis | 668 | $2 | $16 |
| Office visit, established patient (30-39 min) | 493 | $94 | $224 |
| Bladder ultrasound after voiding | 479 | $8 | $94 |
| Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | 357 | $69 | $364 |
| New patient office visit (45-59 min) | 279 | $118 | $343 |
| Yeast/candida DNA test | 238 | $34 | $123 |
| Infectious disease DNA/RNA test | 238 | $34 | $161 |
| Diagnostic exam of bladder and urethra using an endoscope | 171 | $182 | $664 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 119 | $34 | $177 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 119 | $34 | $149 |
| Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 119 | $34 | $149 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 119 | $34 | $123 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 119 | $34 | $123 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 91 | $137 | $928 |
| X-ray of abdomen, 1 view | 77 | $22 | $84 |
| Initial hospital admission, moderate complexity | 77 | $106 | $297 |
| Ct scan of abdomen and pelvis before and after contrast | 70 | $265 | $1,776 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 63 | $282 | $898 |
| Insertion of sacral nerve neurostimulator electrode array | 59 | $290 | $3,698 |
| Blood creatinine level | 59 | $5 | $30 |
| Insertion of device into abdomen with pressure and urine flow rate study | 47 | $148 | $884 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 46 | $25 | $606 |
| Hospital follow-up visit, moderate complexity | 42 | $64 | $157 |
| Urinalysis with microscopic exam | 41 | $3 | $27 |
| Office visit, established patient (20-29 min) | 38 | $63 | $148 |
| Insertion of peripheral or gastric neurostimulator generator | 36 | $65 | $1,142 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 35 | $32 | $215 |
| Complete ultrasound scan behind abdominal cavity | 21 | $77 | $361 |
| Electronic assessment of bladder emptying | 14 | $5 | $269 |
| Ct scan of abdomen and pelvis without contrast | 13 | $132 | $892 |
| Repair of pelvic ligaments through vagina | 12 | $312 | $2,225 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 11 | $648 | $2,094 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. King is a mixed practice specialist, with above-average Medicare volume (top 9% in FL), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. King experienced with contrast dye for imaging (iodine-based)?
Does Dr. King receive payments from pharmaceutical companies?
How do Dr. King's costs compare to other urology physicians in Pensacola?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology